Our data also suggest that IL-33 might protect from CDI by combined downregulation of type 3 signaling, as observed by the decreased expression of Il23r, and upregulation of type 2 signaling, as observed by the increased expression of Il5, Il13, Areg, and Arg1. The gene discussed is IL13; the disease is clostridium difficile infection.